Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Michael Morris (NPI 1437492238)

Field	Value
Entity Type	Individual
Organization	Michael Morris
Address	331 Oak Manor Dr Ste 201
City	Glen Burnie
State	MD
ZIP	21061
Taxonomy	Diagnostic Radiology Physician
NPI Enumerated	March 29, 2013

Payer Source	Total Paid
Medicare	$12M
Medicaid	$0

Key Findings

This provider’s billing footprint is effectively single–payer: total Medicare revenue is $12M while there is no Medicaid billing on file, so Medicare drives the entirety of the observed public-payer volume and the practice appears to rely on Medicare as its primary governmental payer. That concentrated payer mix will shape contracting leverage and must be considered when evaluating network access or reimbursement sensitivity.

Revenue is highly concentrated in a very small number of radiopharmaceutical codes: the precomputed top three Medicare codes account for 90.7% of total Medicare revenue, led by A9607 at $9.1M (76.5%), followed by A9513 at $1.4M (11.4%) and A9595 at $337.3K (2.8%). This degree of concentration indicates that a handful of high-cost therapeutic and diagnostic agents constitute the financial backbone of the provider’s Medicare business.

The CPT/HCPCS mix points to a specialized radioligand/nuclear oncology operation rather than a general diagnostic radiology clinic: A9607 and A9513 are lutetium-based therapeutic agents and A9595 is a diagnostic radiopharmaceutical, while multiple high-volume nuclear imaging and PET/CT codes (for example 78832, 78802, 78815, and 78816) appear throughout the top codes. Together these codes suggest the practice delivers both radiopharmaceutical therapy and associated nuclear imaging services to manage and monitor oncology patients.

Competitive standing is extreme for several radiopharmaceutical and nuclear-imaging codes: A9607 ranks #1 of 44 nationally (100th percentile; extreme outlier), while 78832 ranks #1 of 145 (100th percentile; extreme outlier) and 78802 ranks #1 of 81 (100th percentile; extreme outlier). By contrast, A9513 ranks #2 of 2 nationally (0th percentile; typical, unremarkable volume), indicating that for some specific agents the national provider pool is very small and this site’s relative position varies by product.

Operational throughput is substantial for drug administration and imaging services: claim volumes include 46.6K claims for A9607, 5.6K claims for A9513, 727 claims for A9595, and 4.6K claims for J1930 (lanreotide injections), indicating the practice both administers high volumes of radiopharmaceuticals and supports ancillary injectable therapies. These claim counts, combined with the high-dollar nature of the top codes, imply a clinic workflow oriented to repeat therapeutic administrations and serial imaging studies.

The practice also shows a notable footprint in radiation therapy planning and dosimetry: 77300 appears with 1.8K claims and $102.9K revenue (rank #17 of 4719; 100th percentile; extreme outlier) and 77263 appears with 218 claims and $30.7K revenue (rank #43 of 4379; 99th percentile; extreme outlier). These entries indicate integrated radiation oncology planning activities consistent with complex cancer care pathways alongside radiopharmaceutical treatment.

Tenure data show the NPI was enumerated on 2013-03-29 (~13 years ago), suggesting the provider has an established billing history in Medicare that enabled development of a concentrated, specialized service line over time. That longevity supports the plausibility of built-up clinical programs for radioligand therapy and associated imaging.

The financial profile implies business concentration risk and payer-exposure considerations: because A9607 and A9513 dominate revenue (together driving the majority of Medicare dollars) the provider’s revenue is sensitive to utilization or pricing changes for those agents and to Medicare coverage policy. Additionally, the absence of Medicaid billing means the provider’s public-payer exposure is concentrated in Medicare and potentially commercial payers, which may affect negotiations and access in managed Medicaid networks.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

35 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
A9607	Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie	46,630	$200	$9.1M
A9513	Lutetium lu 177, dotatate, therapeutic, 1 millicurie	5,600	$240	$1.4M
A9595	Piflufolastat f-18, diagnostic, 1 millicurie	730	$460	$337.3K
78832	The provider uses a nuclear imaging test called SPECT with concurrent CT imaging to localize a tumor, inflammatory process, or radioactive tracer distribution. Vascular flow and blood pool imaging…	530	$470	$249.4K
J1930	Injection, lanreotide, 1 mg	4,560	$40	$200.6K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	340	$500	$167K
77300	Radiation therapy is one of the most effective treatment methods for cancerous tumors. Due to its negative side effects like damage to the healthy cells, radiation therapy involves thorough planning…	1,840	$60	$102.9K
78802	The provider uses a gamma–emitting radioactive tracer to diagnose and localize a tumor, inflammatory process, or radiopharmaceutical agent distribution. Vascular flow and blood pool imaging to…	540	$160	$84K
A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	80	$670	$51.9K
A9587	Gallium ga-68, dotatate, diagnostic, 0.1 millicurie	440	$120	$51.4K

Showing 1–10 of 35

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 35 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Michael Morris — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

35 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
A9607	1	10	46,630	$200	$9.1M
A9513	1	10	5,600	$240	$1.4M
A9596	3	10	210	$700	$203.3K
J1930	1	10	4,560	$40	$200.8K
78815	22	110	110	$830	$173.4K
A9595	4	40	290	$510	$169.9K
78832	1	10	50	$410	$85.4K
78802	1	10	540	$160	$83.8K
A9587	3	10	420	$100	$48.5K
78816	8	60	30	$770	$35.5K

Showing 1–10 of 35

Related Providers

Other providers that share a Tax Identification Number (TIN) with Michael Morris, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Miami Hospital And Clinics	FL	Special Hospital	$0	$62.1M
The Milton S. Hershey Medical Center Physicians Group	PA	Sports Medicine (Neuromusculoskeletal Medicine) Physician	$0	$26.6M
Maryland Family Care, Inc.	MD	Family Medicine Physician	$0	$24.6M
St Paul Place Specialists, Inc.	MD	Dermatology Physician	$0	$13.3M
Penn State Health Medical Group, LLC	PA	Pediatrics Physician	$0	$7.7M
University Of Miami	FL	Anatomic Pathology & Clinical Pathology Physician	$0	$7.4M
Richard Huslig	MD	Hematology & Oncology Physician	$4.9M	$0
Jorge Fortun	FL	Ophthalmology Physician	$3.7M	$0
St Paul Place Specialists, Inc.	MD	Clinical Pathology/Laboratory Medicine Physician	$2.7M	$948.8K
Jaclyn Kovach	FL	Ophthalmology Physician	$3.1M	$0

Nearby Providers

Other providers in the same ZIP code as Michael Morris, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Catholic Charities, Inc.	MD	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$22.9M
Kimmar Medical Associates	MD	Nursing Care Agency	$0	$15.8M
Elevate Recovery Centers LLC	MD	Substance Use Disorder Rehabilitation Clinic/Center	$0	$15.3M
People Encouraging People, Inc.	MD	Mental Health Counselor	$0	$15M
E J A L Health Services Inc	MD	Methadone Clinic	$0	$14.5M
Greenway Orthodontics LLC	MD	Orthodontics and Dentofacial Orthopedics Dentistry	$0	$12M
Allcare Treatment Services, LLC	MD	Methadone Clinic	$272.6K	$10.3M
Baltimore Washington Emergency Physicians, Inc.	MD	Emergency Medicine Physician	$0	$10.3M
Omni House Inc	MD	Mental Illness Community Based Residential Treatment Facility	$0	$10.1M
Grace House Iop, LLC	MD	Substance Use Disorder Rehabilitation Clinic/Center	$0	$9.8M

Michael Morris — Billing Profile & Reimbursement Data

Sign up for Michael Morris — Billing Profile & Reimbursement Data policy alerts

Michael Morris — Billing Profile & Reimbursement Data

Sign up for Michael Morris — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References